Drug intelligence / Profile preview

ViscoCell

Development stage: Preclinical
Lead developer: Likarda
Modality: Stem Cell Therapies → Cell Therapies, Hydrogel Systems → Drug Delivery Systems
Administration: Intraarticular

Overview

ViscoCell is an injectable hydrogel-based delivery platform developed by Likarda for the treatment of osteoarthritis. It utilizes Likarda's proprietary Core-Shell Spherification (CSS) technology to encapsulate therapeutic agents, such as mesenchymal stem cells (MSCs) or biologics, within hydrogel microbeads. The hydrogel is specifically engineered to match the viscoelastic properties of synovial fluid, providing both viscosupplementation and a protective environment for the delivered cells. This system aims to improve cell retention and therapeutic efficacy within the joint, promoting cartilage repair and reducing inflammation. In preclinical studies, stem cells delivered via ViscoCell showed improved outcomes in osteoarthritic models, resulting in the restoration of healthy cartilage surfaces.

Brand names: ViscoCell
Other names: ViscoCell-Likarda

Beyond the preview

Go deeper on ViscoCell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViscoCell.

Explore the full profile